Cochleopathy in Egyptian adolescents with Type 1 diabetes mellitus

International Journal of Pediatric Otorhinolaryngology

Volumn 76, Issue 11, 2012, Pages 1558-1564

  Elbarbary, Nancy S ^a   El Kabarity, Rasha H ^a   El Desouky, Eman D ^b  

^a AIN SHAMS UNIVERSITY   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

Children and adolescents; Inner hair cells; Otoacoustic emissions; Otoacoustic emissions with contralateral suppression; TEN Test; Type 1 diabetes

Indexed keywords

HEMOGLOBIN A1C;

ADOLESCENT; ADULT; ARTICLE; AUDITORY NERVOUS SYSTEM; AUDITORY THRESHOLD; AUTONOMIC NEUROPATHY; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE DURATION; EGYPT; EVOKED OTOACOUSTIC EMISSION; FEMALE; HAIR CELL; HEARING IMPAIRMENT; HEARING TEST; HUMAN; HYPERGLYCEMIA; INNER EAR DISEASE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; OLIVOCOCHLEAR TRACT; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; THRESHOLD EQUALIZING NOISE TEST;

ACOUSTIC IMPEDANCE TESTS; ADOLESCENT; ASYMPTOMATIC DISEASES; AUDIOMETRY; AUDITORY THRESHOLD; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETIC NEUROPATHIES; DIABETIC RETINOPATHY; EGYPT; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; OTOACOUSTIC EMISSIONS, SPONTANEOUS;

EID: 84867732040     PISSN: 01655876     EISSN: 18728464     Source Type: Journal    
DOI: 10.1016/j.ijporl.2012.07.010     Document Type: Article

References (49)

1. Van den Driessche A., Eenkhoorn V., Van Gaal L., De Block C. Type 1 diabetes and autoimmune polyglandular syndrome: a clinical review. Neth. J. Med. 2009, 67(December (11)):376-387. (review).
2. Schalkwijk C.G., Stehouwer C.D. Vascular complications in diabetes mellitus: the role of endothelial dysfunction. Clin. Sci. (Lond.) 2005, 109(August (2)):143-159.
3. Uzun N., Uluduz D., Mikla S., Aydin A. Evaluation of asymptomatic central neuropathy in type I diabetes mellitus. Electromyogr. Clin. Neurophysiol. 2006, 46(May-June (3)):131-137.
4. Cullen J.R., Cinnamond M.J. Hearing loss in diabetics. J. Laryngol. Otol. 1993, 107:179-182.
5. Ottaviani F., Dozio N., Neglia C.B., Riccio S., Scavini M. Absence of otoacoustic emissions in insulin-dependent diabetic patients. Is there evidence for diabetic cochleopathy?. J. Diabetes Complications 2002, 16:338-343.
6. Probst R., Lonsbury-Martin B., Martin G. A review of otoacoustic emissions. J. Aoust. Soc. Am. 1991, 89:2027-2067.
7. Driscoll C., Kei J., Murdoch B., Symth V., Latham S. Transient evoked otoacoustic emissions in two-months old infants: a normative study. Audiology 1999, 38:181-186.
8. Noback Neuroanatomical correlates of central auditory function. Assessment of Central Auditory Dysfunction. Foundation and Clinical Correlates 1985, Williams and Wilkins, Baltimore, pp. 7-21. 9th ed. M.L. Pinheiro, F.E. Musiek (Eds.).
9. Lifshitz F. Pediatric Endocrinology. Vol. 1: Obesity, Diabetes Mellitus, Insulin. Resistance and Hypoglycemia 2007, Informa Healthcare, New York. 5th ed.
10. Jerger J. Clinical experience with impedance audiometry. Arch. Otolaryngol. 1970, 92(4):311-324.
11. Penner M.J., Glotzbach L., Huang T. Spontaneous otoacoustic emissions: measurement and data. Hear. Res. 1993, 68(2):229-237.
12. Kemp D.T., Ryan S., Bray P. A guide to the effective use of otoacoustic emissions. Ear Hear 1990, 11(2):93-105.
13. Stuart A., Preast J. Contralateral suppression of transient-evoked otoacoustic emissions in children with sickle cell disease. Ear Hear 2012, 33(3):421-429.
14. Guinan J.J. Olivocochlear efferents: anatomy, physiology, function, and the measurement of efferent effects in humans. Ear Hear 2006, 27(December (6)):589-607.
15. Arslan R., Ozdamar O., Ulgen Y. Digital subtraction method for transient evoked otoacoustic emission recording with ipsilateral noise suppression: an application to stimulus artifact reduction. Audiology 2001, 40:55-62.
16. Folsum R., Owsley R. N1 action potentials in humans. Influence of simultaneous contralateral stimulation. Acta Otolaryngol. 1987, 103(March-April (3-4)):262-265.
17. Moore B., Alcantara J., Marriage J. Comparison of three procedures for initial fitting of comparison hearing aids. I. Eperienced users, fitted binaurally. Br. J. Audiol. 2001, 35:339-363.
18. Thabet E.M. Evaluation of tinnitus patients with normal hearing sensitivity using TEOAEs and TEN test. Auris Nasus Larynx 2009, 36(December (6)):633-636.
19. Gordo A., Martinelli Iório M.C. Dead regions in the cochlea at high frequencies: implications for the adaptation to hearing aids. Braz. J. Otorhinolaryngol. 2007, 73(May-June (3)):299-307.
20. American-speech-language-hearing association ASHA panel on audiologic assessment, 1997. http://www.asha.org/docs/html/gl.
21. American National Standards Institute Important revision of ANSI S3. 6-1989: ANSI S3. 6-1996. American National standard specification for audiometers. J. Speech Lang. Pathol. Audiol. 1996, 22(1).
22. Weintrob N., Amitay I., Klein R.E., Lilos P., Shalitin S., Lazar L., et al. Bedside neuropathy disability score compared to quantitative sensory testing for measurement of diabetic neuropathy in children, adolescents, and young adults with type 1 diabetes. J. Diabetes Complications 2007, 21(1):13-19.
23. Ewing D.J., Clarke B.F., Davis M. Diagnosis and management of diabetic autonomic neuropathy. Br. Med. J. (Clin. Res. Ed.) 1982, 285:916-918.
24. Wilkinson C.P., Ferris F.L., Klein R.E., Lee P.P., Agardh C.D., Davis M., et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 2003, 110:1677-1682.
25. Maxon A., White K., Vohr B., Behrens T. Feasibility of identifying risk for conductive hearing loss in a newborn universal screening program. Semin. Hear. 1993, 14:73-87.
26. Johnson J.L., White K.R., Widen J.E., Gravel J.S., Vohr B.R., James M., et al. A multisite study to examine the efficacy of the otoacoustic emission/automated auditory brainstem response newborn hearing screening protocol: introduction and overview of the study. Am. J. Audiol. 2005, 14(December (2)):S178-S185.
27. Tabaei B., Al-Kassab A., Zawaski C., Herman W. Does microalbuminuria predict diabetic nephropathy?. Diabetic Care 2001, 24(9):1560-1566.
28. Maia C.A., Campos C.A. Diabetes mellitus as etiological factor of hearing loss. Braz. J. Otorhinolaryngol. 2005, 71(March-April (2)):208-214.
29. Fedele D., Martini A., Cardone C., Comacchio F., Bellavere F., Molinari G., et al. Impaired auditory brainstem-evoked responses in insulin-dependent diabetic subjects. Diabetes 1984, 33(11):1085-1089.
30. Khardori R., Soler N.G., Good D.C., DevlescHoward A.B., Broughton D., Walbert J. Brainstem auditory and visual evoked potentials in type 1 (insulin-dependent) diabetic patients. Diabetologia 1986, 29(6):362-365.
31. Martini A., Comacchio F., Magnavita V. Auditory brainstem and middle latency evoked responses in the clinical evaluation of diabetes. Diabetic Med. 1991, 8:S74-S77.
32. Virtaniemi J., Laakso M., Karja J., Nuutinen J., Karjalainen S. Auditory brainstem latencies in type I (insulin-dependent) diabetic patients. Am. J. Otolaryngol. 1993, 14(6):413-418.
33. Bayazit Y., Yilmaz M., Kepekci Y., Mumbuc S., Kanlikama M. Use of the auditory brainstem response testing in the clinical evaluation of the patients with diabetes mellitus. J. Neurol. Sci. 2000, 181(1/2):29-32.
34. Várkonyi T.T., Tóth F., Rovó L., Lengyel C., Kiss J.G., Kempler P., et al. Impairment of auditory brainstem function in diabetic neuropathy. Diabetes Care 2002, 25(3):631-632.
35. ElDanasoury I., AbdelMaksoud A., Habib A. Assessment of olivocochlear bundle in insulin-dependent diabetic children. Ain Shams Med. J. 2001, 52(10, 11 and 12):1337-1350.
36. Smith T.L., Raynor E., Prazma J., Buenting J.E., Pillsbury H.C. Insulinodependent diabetic microangiopathy in the inner ear. J. Laringol. Otol. 1995, 105:236-240.
37. Raynor E.M., Carrasco V.N., Prazma J., Pillsbury H.C. An assessment of cochlear hair - cell loss in insulin - dependent diabetes mellitus diabetic and noise-exposed rats. Arch. Otolaryngol. Head Neck Surg. 1995, 121:452-456.
38. Pudar G., Vlaski L., Filipović D., Tanackov I. Correlation of hearing function findings in patients suf-fering from diabetes mellitus type 1 in regard to age and gender. Med. Pregl. 2009, 62:395-401.
39. Dabrowski M., Mielnik-Niedzielska G., Nowakowski A. Involvement of the auditory organ in type 1 diabetes mellitus. Endokrynol. Pol. 2011, 62(2):138-144.
40. Ugur A.K., Kemaloglu Y.K., Ugur M.B., Gunduz B., Saridogan C., Yesilkaya E., et al. Otoacoustic emissions and effects of contralateral white noise stimulation on transient evoked otoacoustic emissions in diabetic children. Int. J. Pediatr. Otorhinolaryngol. 2009, 73(April (4)):555-559.
41. Di Leo M.A., Di Nardo W., Cercone S., Ciervo A., Lo Monaco M., Greco A.V., et al. Cochlear dysfunction in IDDM patients with subclinical peripheral neuropathy. Diabetes Care 1997, 20:824-828.
42. Elamin A., Fadlallah M., Tuevmo T. Hearing loss in children with type 1 diabetes. Indian Pediatr. 2005, 42:15-21.
43. Pessin A.B.B., Martins R.H.G., Pimenta W.P., Simões A.C.P., Marsiglia A., Amaral A. Auditory evaluation in patients with type 1 diabetes. Ann. Otol. Rhinol. Laryngol. 2008, 117:366-370.
44. Rust K.R., Prazma J., Triana R.J., Michaelis O.E., Pillsbury H.C. Inner ear damage secondary to diabetes mellitus. Arch. Otolaryngol. Head Neck Surg. 1992, 118:397-400.
45. Sasso F.C., Salvatore T., Tranchino G., Cozzolino D., Caruso A.A., Persico M., et al. Cochlear dysfunction in type 2 diabetes: a complication independent of neuropathy and acute hyperglycemia. Metabolism 1999, 48(November (11)):1346-1350.
46. Kondo J., Tachibana H., Inuzumi K., Miyauchi M., Matsuoka A., Takeda M., et al. Involvement of central nervous system in patients with diabetes mellitus detected by evoked potentials. Rinsho-Byori 1990, 38:457-462.
47. Martini A., Comacchio F., Fedele D., Crepaldi G., Sala O. Auditory brainstem evoked responses in the clinical evaluation and follow-up of insulin-dependent diabetic subjects. Acta Otolaryngol. (Stockholm) 1987, 103:620-627.
48. Robbins S.L., Cotran R.S., Kumar V. Pathologic Basis of Disease 1991, W.B. Sauders Co., Philadelphia, pp. 982-983. 3rd ed.
49. Frisina S.T., Mapes F., Kim S., Frisina D.R., Frisina R.D. Characterization of hearing loss in aged type II diabetics. Hear. Res. 2006, 211(January (1-2)):103-113.